ERISNSEEris Lifesciences LimitedMediumNeutral
Announced Thu, 23 Apr · 17:13 IST

Eris Lifesciences Limited has informed the Exchange regarding Notice of Postal Ballot

Board & Shareholder Meetings View source PDF

ERIS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.9%1-day move
₹1399.00
prior close
₹1399.80
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.2+0.6+0.3-0.1-2.9-4.9-5.8-5.6-3.0-1.7-4.7-3.2+4.3-0.2
Up moveDown movePending
AI summary

Eris Lifesciences Limited is seeking shareholder approval via postal ballot (electronic voting) to appoint Mr. Vineet Varma as a Non-Executive Independent Director for a term of 5 years (March 14, 2026 to March 13, 2031). Mr. Varma, aged approximately 66 years, brings 25+ years of experience from international banks including First Abu Dhabi Bank and ABN Amro Bank, specializing in transaction banking, trade, treasury, and corporate banking. He is an alumnus of London Business School and Shriram College of Commerce, New Delhi. He was previously appointed as Additional Director and this postal ballot is to regularize his appointment with shareholder consent. The e-voting period runs from April 24, 2026 to May 23, 2026, with the cut-off date for eligible voters being April 17, 2026. The resolution requires a special majority approval.

Likely market impact

The appointment of an experienced independent director strengthens the board's expertise in financial services and corporate banking, which is positive for corporate governance. This appointment is unlikely to have any immediate impact on the stock price but enhances board independence and oversight capabilities.